{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T19:47:07Z","timestamp":1775072827079,"version":"3.50.1"},"reference-count":32,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T00:00:00Z","timestamp":1682640000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"},{"start":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T00:00:00Z","timestamp":1682640000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>The globalization of clinical trials has highlighted geographic differences in patient characteristics, treatments, and outcomes. We examined these differences in PARADISE-MI.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>Overall, 23.0% were randomized in Eastern Europe\/Russia, 17.5% in Western Europe, 12.2% in Southern Europe, 10.1% in Northern Europe, 12.0% in Latin America (LA), 9.3% in North America (NA), 10.0% in East\/South-East Asia and 5.8% in South Asia (SA). Those from Asia, particularly SA, were different from patients enrolled in the other regions, being younger and thinner. They also differed in terms of comorbidities (high prevalence of diabetes and low prevalence of atrial fibrillation), type of myocardial infarction (more often ST-elevation myocardial infarction), and treatment (low rate of primary percutaneous coronary intervention). By contrast, patients from LA did not differ meaningfully from those randomized in Europe or NA. Use of angiotensin-converting enzyme inhibitors\/angiotensin receptor blockers (34.8%) and beta-blockers (65.5%) was low in SA, whereas mineralocorticoid receptor antagonist use was lowest in NA (22%) and highest in Eastern Europe\/Russia (53%). Rates of the primary composite outcome of cardiovascular death or incident heart failure varied two-fold among regions, with the lowest rate in SA (4.6\/100\u2009person-years) and the highest in LA (9.2\/100\u2009person-years). Rates of incident heart failure varied almost six-fold among regions, with the lowest rate in SA (1.0\/100\u2009person-years) and the highest in Northern Europe (5.9\/100\u2009person-years). The effect of sacubitril\/valsartan was not modified by region.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In PARADISE-MI, there were substantial regional differences in patient characteristics, treatments and outcomes. Although the generalizability of these findings to a \u2018real-world\u2019 unselected population may be limited, these findings underscore the importance of considering both regional and within-region differences when designing global clinical trials.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/ejhf.2851","type":"journal-article","created":{"date-parts":[[2023,4,12]],"date-time":"2023-04-12T02:40:14Z","timestamp":1681267214000},"page":"1228-1242","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Geographic Differences in Patients with Acute Myocardial Infarction in the PARADISE-MI Trial"],"prefix":"10.1093","volume":"25","author":[{"given":"Jawad H.","family":"Butt","sequence":"first","affiliation":[{"name":"British Heart Foundation Cardiovascular Research Centre, University of Glasgow , Glasgow ,","place":["UK"]},{"name":"Department of Cardiology, Rigshospitalet Copenhagen University Hospital , Copenhagen ,","place":["Denmark"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian L.","family":"Claggett","sequence":"additional","affiliation":[{"name":"Cardiovascular Division, Brigham and Women's Hospital , Boston, MA ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zi M.","family":"Miao","sequence":"additional","affiliation":[{"name":"Cardiovascular Division, Brigham and Women's Hospital , Boston, MA ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karola S.","family":"Jering","sequence":"additional","affiliation":[{"name":"Cardiovascular Division, Brigham and Women's Hospital , Boston, MA ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Sim","sequence":"additional","affiliation":[{"name":"National Heart Center Singapore , Singapore ,","place":["Singapore"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"van der Meer","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University Medical Center Groningen, University of Groningen , Groningen ,","place":["The Netherlands"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mpiko","family":"Ntsekhe","sequence":"additional","affiliation":[{"name":"Division of Cardiology, University of Cape Town & Groote Schuur Hospital , Cape Town ,","place":["South Africa"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Offer","family":"Amir","sequence":"additional","affiliation":[{"name":"Cardiovascular Institute, Hadassah Medical Center , Jerusalem ,","place":["Israel"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myeong-Chan","family":"Cho","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Cardiocerebrovascular Center, Chungbuk National University Hospital , Cheongju ,","place":["South Korea"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge","family":"Carrillo-Calvillo","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Hospital Central \u2018Dr. Ignacio Morones Prieto\u2019 San Luis Potos\u00ed , San Luis Potos\u00ed ,","place":["Mexico"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julio E.","family":"N\u00fa\u00f1ez","sequence":"additional","affiliation":[{"name":"Cardiology Department, Hospital Cl\u00ednico Universitario de Valencia, INCLIVA Instituto de Investigaci\u00f3n Sanitaria , Valencia ,","place":["Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Cadena","sequence":"additional","affiliation":[{"name":"Cl\u00ednica de la Costa LTDA , Barranquilla ,","place":["Colombia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prafulla","family":"Kerkar","sequence":"additional","affiliation":[{"name":"Department of Cardiology, KEM Hospital , Mumbai, Maharashtra ,","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aldo P.","family":"Maggioni","sequence":"additional","affiliation":[{"name":"ANMCO Research Center , Florence ,","place":["Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe G.","family":"Steg","sequence":"additional","affiliation":[{"name":"Universit\u00e9 de Paris, AP-HP (Assistance Publique-H\u00f4pitaux de Paris), FACT (French Alliance for Cardiovascular Trials) and INSERM U-1148 , Paris ,","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher B.","family":"Granger","sequence":"additional","affiliation":[{"name":"Duke University Medical Center , Durham, NC ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas L.","family":"Mann","sequence":"additional","affiliation":[{"name":"Department of Medicine, Washington University , St. Louis, MO ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B\u00e9la","family":"Merkely","sequence":"additional","affiliation":[{"name":"Heart and Vascular Centre, Semmelweis University , Budapest ,","place":["Hungary"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eldrin F.","family":"Lewis","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Stanford University , Palo Alto, CA ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott D.","family":"Solomon","sequence":"additional","affiliation":[{"name":"Cardiovascular Division, Brigham and Women's Hospital , Boston, MA ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yinong","family":"Zhou","sequence":"additional","affiliation":[{"name":"Novartis Pharmaceutical Corporation , East Hanover, NJ ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars","family":"K\u00f8ber","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Rigshospitalet Copenhagen University Hospital , Copenhagen ,","place":["Denmark"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugene","family":"Braunwald","sequence":"additional","affiliation":[{"name":"Cardiovascular Division, Brigham and Women's Hospital , Boston, MA ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John J.V.","family":"McMurray","sequence":"additional","affiliation":[{"name":"British Heart Foundation Cardiovascular Research Centre, University of Glasgow , Glasgow ,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc A.","family":"Pfeffer","sequence":"additional","affiliation":[{"name":"Cardiovascular Division, Brigham and Women's Hospital , Boston, MA ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2023,4,28]]},"reference":[{"key":"2026010913103585200_ejhf2851-bib-0001","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1002\/ejhf.1585","article-title":"Heart failure around the world","volume":"21","author":"Tromp","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"2026010913103585200_ejhf2851-bib-0002","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1002\/ejhf.1130","article-title":"Globalization of heart failure clinical trials: a systematic review of 305 trials conducted over 16\u2009years","volume":"20","author":"Vaduganathan","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"2026010913103585200_ejhf2851-bib-0003","first-page":"11","article-title":"Angiotensin receptor-neprilysin inhibitor in acute myocardial infarction","volume":"70","author":"Pathak","year":"2022","journal-title":"J Assoc Physicians India"},{"key":"2026010913103585200_ejhf2851-bib-0004","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ahj.2017.09.003","article-title":"Global geographical variation in patient characteristics in percutaneous coronary intervention clinical trials: a systematic review and meta-analysis","volume":"195","author":"Liu","year":"2018","journal-title":"Am Heart J"},{"key":"2026010913103585200_ejhf2851-bib-0005","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1056\/NEJMsb0803929","article-title":"Ethical and scientific implications of the globalization of clinical research","volume":"360","author":"Glickman","year":"2009","journal-title":"N Engl J Med"},{"key":"2026010913103585200_ejhf2851-bib-0006","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.120.007901","article-title":"Global differences in heart failure with preserved ejection fraction: the PARAGON-HF trial","volume":"14","author":"Tromp","year":"2021","journal-title":"Circ Heart Fail"},{"key":"2026010913103585200_ejhf2851-bib-0007","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1093\/eurheartj\/ehw226","article-title":"Geographic variations in the PARADIGM-HF heart failure trial","volume":"37","author":"Kristensen","year":"2016","journal-title":"Eur Heart J"},{"key":"2026010913103585200_ejhf2851-bib-0008","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1161\/CIRCULATIONAHA.114.012284","article-title":"International geographic variation in event rates in trials of heart failure with preserved and reduced ejection fraction","volume":"131","author":"Kristensen","year":"2015","journal-title":"Circulation"},{"key":"2026010913103585200_ejhf2851-bib-0009","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jchf.2020.11.007","article-title":"Impact of geographic region on the COMMANDER-HF trial","volume":"9","author":"Ferreira","year":"2021","journal-title":"JACC Heart Fail"},{"key":"2026010913103585200_ejhf2851-bib-0010","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.cct.2004.08.005","article-title":"Geographic variability in patient characteristics, treatment and outcome in an international trial of magnesium in acute myocardial infarction","volume":"25","author":"Domanski","year":"2004","journal-title":"Control Clin Trials"},{"key":"2026010913103585200_ejhf2851-bib-0011","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.ahj.2006.02.032","article-title":"Geographic variation in the treatment of acute myocardial infarction in the VALsartan In Acute myocardial iNfarcTion (VALIANT) trial","volume":"152","author":"Reed","year":"2006","journal-title":"Am Heart J"},{"key":"2026010913103585200_ejhf2851-bib-0012","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1016\/j.amjcard.2016.03.002","article-title":"Geographic differences in patients in a global acute heart failure clinical trial (from the ASCEND-HF trial)","volume":"117","author":"Metra","year":"2016","journal-title":"Am J Cardiol"},{"key":"2026010913103585200_ejhf2851-bib-0013","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1161\/CIRCULATIONAHA.114.013255","article-title":"Regional variation in patients and outcomes in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) trial","volume":"131","author":"Pfeffer","year":"2015","journal-title":"Circulation"},{"key":"2026010913103585200_ejhf2851-bib-0014","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1016\/j.jacc.2008.07.056","article-title":"Continental differences in clinical characteristics, management, and outcomes in patients hospitalized with worsening heart failure. Results from the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan) program","volume":"52","author":"Blair","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"2026010913103585200_ejhf2851-bib-0015","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1002\/ejhf.92","article-title":"International differences in clinical characteristics, management, and outcomes in acute heart failure patients: better short-term outcomes in patients enrolled in Eastern Europe and Russia in the PROTECT trial","volume":"16","author":"Mentz","year":"2014","journal-title":"Eur J Heart Fail"},{"key":"2026010913103585200_ejhf2851-bib-0016","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.jacc.2011.03.057","article-title":"Influence of global region on outcomes in heart failure beta-blocker trials","volume":"58","author":"O'Connor","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"2026010913103585200_ejhf2851-bib-0017","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1161\/CIRCULATIONAHA.111.047498","article-title":"Ticagrelor compared with clopidogrel by geographic region in the Platelet Inhibition and Patient Outcomes (PLATO) trial","volume":"124","author":"Mahaffey","year":"2011","journal-title":"Circulation"},{"key":"2026010913103585200_ejhf2851-bib-0018","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1002\/ejhf.2191","article-title":"Prospective ARNI vs. ACE inhibitor trial to DetermIne Superiority in reducing heart failure Events after Myocardial Infarction (PARADISE-MI): design and baseline characteristics","volume":"23","author":"Jering","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"2026010913103585200_ejhf2851-bib-0019","volume-title":"Standard Country or Area Codes for Statistical Use (M49)"},{"key":"2026010913103585200_ejhf2851-bib-0020","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1007\/s00392-018-1254-y","article-title":"Regional variations in hospital management and post-discharge mortality in patients with non-ST-segment elevation acute coronary syndrome","volume":"107","author":"Bueno","year":"2018","journal-title":"Clin Res Cardiol"},{"key":"2026010913103585200_ejhf2851-bib-0021","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ijcard.2017.07.039","article-title":"Global geographical variations in ST-segment elevation myocardial infarction management and post-discharge mortality","volume":"245","author":"Rossell\u00f3","year":"2017","journal-title":"Int J Cardiol"},{"key":"2026010913103585200_ejhf2851-bib-0022","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1080\/01621459.1987.10478502","article-title":"Regression methods for Poisson process data","volume":"82","author":"Lawless","year":"1987","journal-title":"J Am Stat Assoc"},{"key":"2026010913103585200_ejhf2851-bib-0023","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.recesp.2021.05.017","article-title":"Survival analyses in cardiovascular research, part I: the essentials","volume":"75","author":"Rossello","year":"2022","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"key":"2026010913103585200_ejhf2851-bib-0024","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.recesp.2021.06.027","article-title":"Survival analyses in cardiovascular research, part II: statistical methods in challenging situations","volume":"75","author":"Rossello","year":"2022","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"key":"2026010913103585200_ejhf2851-bib-0025","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ijcard.2009.03.036","article-title":"Transatlantic similarities and differences in major natural history endpoints of heart failure after acute myocardial infarction: a propensity-matched study of the EPHESUS trial","volume":"143","author":"Pitt","year":"2010","journal-title":"Int J Cardiol"},{"key":"2026010913103585200_ejhf2851-bib-0026","doi-asserted-by":"crossref","first-page":"469","DOI":"10.4070\/kcj.2019.0136","article-title":"Sacubitril\/valsartan in Asian patients with heart failure with reduced ejection fraction","volume":"49","author":"Dewan","year":"2019","journal-title":"Korean Circ J"},{"key":"2026010913103585200_ejhf2851-bib-0027","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.1093\/eurheartj\/ehw331","article-title":"Regional and ethnic differences among patients with heart failure in Asia: the Asian sudden cardiac death in heart failure registry","volume":"37","author":"Lam","year":"2016","journal-title":"Eur Heart J"},{"key":"2026010913103585200_ejhf2851-bib-0028","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/eurheartj\/ehx393","article-title":"2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation","volume":"39","author":"Ibanez","year":"2018","journal-title":"Eur Heart J"},{"key":"2026010913103585200_ejhf2851-bib-0029","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1093\/eurheartj\/ehaa575","article-title":"2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation","volume":"42","author":"Collet","year":"2021","journal-title":"Eur Heart J"},{"key":"2026010913103585200_ejhf2851-bib-0030","first-page":"e344","article-title":"2014 AHA\/ACC Guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"130","author":"Amsterdam","year":"2014","journal-title":"Circulation"},{"key":"2026010913103585200_ejhf2851-bib-0031","first-page":"e362","article-title":"2013 ACCF\/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"127","author":"O'Gara","year":"2013","journal-title":"Circulation"},{"key":"2026010913103585200_ejhf2851-bib-0032","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1002\/ejhf.326","article-title":"Geographic differences in heart failure trials","volume":"17","author":"Ferreira","year":"2015","journal-title":"Eur J Heart Fail"}],"container-title":["European Journal of Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurjhf\/article-pdf\/25\/8\/1228\/65494689\/eurjhf_25_8_1228.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurjhf\/article-pdf\/25\/8\/1228\/65494689\/eurjhf_25_8_1228.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T18:13:13Z","timestamp":1767982393000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurjhf\/article\/25\/8\/1228\/8341900"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,28]]},"references-count":32,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2023,4,28]]},"published-print":{"date-parts":[[2023,8,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ejhf.2851","relation":{},"ISSN":["1388-9842","1879-0844"],"issn-type":[{"value":"1388-9842","type":"print"},{"value":"1879-0844","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,8]]},"published":{"date-parts":[[2023,4,28]]},"assertion":[{"value":"2022-09-14","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-04-08","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-04-28","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}